 SEATTLE, Sept. 03, 2021 GLOBE NEWSWIRE -- Nautilus Biotechnology, Inc. NASDAQ: NAUT; or Nautilus, a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference. 